BioSpace News Archive

Press Releases

Theralase(R) Launches New Clinical Study Site in Canada

December 6, 2024
·
9 min read
Press Releases

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

December 6, 2024
·
11 min read
Press Releases

Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

December 6, 2024
·
7 min read
Press Releases

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2024

December 6, 2024
·
3 min read
Press Releases

Sarah Cannon Research Institute to Showcase Latest Research Insights at the 2024 ASH Annual Meeting & Exposition

December 6, 2024
·
4 min read
Press Releases

Protara Announces Positive Results from the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

December 6, 2024
·
8 min read
Press Releases

BioVaxys Shares New Data on its DPX™ Immune Educating Platform at Personalized Cancer Vaccine Summit

December 6, 2024
·
8 min read
Press Releases

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

December 6, 2024
·
6 min read
Press Releases

STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

December 6, 2024
·
2 min read
Press Releases

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

December 6, 2024
·
6 min read